Virinchi Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, showcasing strong standalone performance despite mixed consolidated results. The Board of Directors approved the results at their meeting held on February 04, 2026.

Standalone Financial Performance

The company delivered impressive standalone results for Q3FY26, with significant improvements across key financial metrics:

For the nine months ended December 31, 2025, standalone revenue from operations reached ₹12,338.40 lacs compared to ₹10,269.50 lacs in the corresponding period last year, representing a growth of 20.15%. Net profit for the nine-month period stood at ₹2,208.20 lacs versus ₹1,433.05 lacs, marking a 54.09% increase.

Segment-wise Performance Analysis

The SAAS Business segment remained the primary revenue contributor, generating ₹4,020.16 lacs in Q3FY26 compared to ₹3,444.53 lacs in Q3FY25. The IT Enabled Services segment also showed strong growth, contributing ₹263.54 lacs versus ₹148.36 lacs in the previous year.

Consolidated Results Show Mixed Performance

While standalone results were robust, consolidated performance presented a more complex picture. Consolidated revenue from operations for Q3FY26 was ₹7,688.82 lacs compared to ₹8,240.31 lacs in Q3FY25, reflecting a decline of 6.69%. Net profit after tax stood at ₹159.65 lacs versus ₹371.04 lacs in the previous year.

Operational Highlights

The company maintained strong operational efficiency with controlled expense management. Employee costs for standalone operations increased to ₹1,813.61 lacs in Q3FY26 from ₹1,271.38 lacs in Q3FY25, reflecting business expansion and talent acquisition initiatives. Finance costs decreased to ₹273.42 lacs from ₹351.73 lacs, indicating improved financial management.

Corporate Structure and Business Segments

Virinchi Limited operates through 13 subsidiaries across four major business segments: SAAS Business (US Fintech), IDC & IT Services, Health Care Services, and Payment & Credit Services (India Fintech). Key subsidiaries include Virinchi Health Care Private Limited, KSoft Systems Inc., and various technology-focused entities. The company's paid-up share capital remained stable at ₹10,264.69 lacs with a face value of ₹10 per share.

Virinchi Limited has completed the allotment of 10,50,000 equity shares following the conversion of warrants issued on a preferential basis, as disclosed to the stock exchanges on January 31, 2026.

Share Allotment Details

The company allotted equity shares of Rs.10.00 each at an issue price of Rs.25.00 per share, representing a premium of Rs.15.00 per share over the face value. The allotment was made upon receipt of application money totaling Rs.1,96,87,500, which represents 75% of the total issue price.

Allottee Information

The entire allotment of 10,50,000 equity shares was made to a single shareholder, Manumon Chettiar, who is categorized as a public shareholder under the preferential allotment framework.

Impact on Share Capital

Following this allotment, Virinchi Limited's issued and subscribed share capital has increased significantly. The company's total share capital now stands at Rs.103,69,68,960, divided into 10,36,96,896 equity shares of Rs.10.00 each.

The allotment was completed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, and the company has duly informed both BSE Limited and National Stock Exchange of India Limited about this corporate action.